InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has entered into a securities purchase agreement with two healthcare-focused institutional investors. The agreement outlines plans for the issuance and sale of 1,818,185 of INM common shares; the shares will be issued at a purchase price … Continue reading “CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding”

AROYA, a METER Group Company, announced that it is incorporating new integrations that extend the utility of its Cannabis Production Platform. The strategic move will enable integrations with third-party systems, further strengthening AROYA’s position as the cannabis industry’s most intuitive platform. The AROYA platform gives growers with control, flexibility, visibility and data-driven insights to help … Continue reading “CannabisNewsBreaks — AROYA Extends Utility of Cannabis Production Platform”

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has named Sarah Li as vice president of accounting and InMed controller; the change will be effective Nov. 20, 2022. Li is replacing Brenda Edwards, who has been serving as interim chief financial officer for the … Continue reading “CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controller”

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, is working to provide viable ways for communities to grow food where it is needed most. The ability to eradicate “food deserts” is a powerful benefit of ACTX’s GrowPods; food deserts are defined by the U.S. Department of Agriculture … Continue reading “CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) GrowPods Can Eliminate Food Deserts Virtually Anywhere”

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced the completion of its new laboratory located in Bogota, Colombia. Specializing in the manufacturing of compound formulations utilizing cannabis derivatives and traditional master formulas, Flora Lab 4 will become part of Flora’s group of laboratories. These include … Continue reading “CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Marks Key Step in Progress Toward Commercializing Medicinal Cannabis”

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has unveiled a new neurodegenerative disease program (“INM-900 series”). The program will focus on studying the effects of cannabinoid analogs in neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s. Prior to this announcement, InMed had identified … Continue reading “CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launches New Program with UBC Professor”

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is working with the 357 Company to launch 357’s Canna Logistics division. The new division is an expansion beyond 357’s Hemp Logistics segment, which ships federally legal hemp within the United States. According to the announcement, the new division … Continue reading “CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Partners with 357 Company to Launch Cannabis Division”

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has reported its financial results for the first quarter of fiscal year 2023, ended Sept. 30, 2022. Highlights of the report included updates on the company’s pharmaceutical development programs, including INM-755 for the treatment of epidermolysis bullosa (“EB”) and INM-088 for … Continue reading “CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2023 Financial Report, Corporate Update”

While economies worldwide are struggling to control spiking inflation rates, REZYFi, a mortgage lender servicing non-traditional as well as other loans, sees unique financial opportunities Through the use of proprietary automated machine learning and associated technologies, together with preparations to launch a high-margin cannabis division later this year to serve an industry in need of … Continue reading “Specialized Market Lender REZYFi, Inc. Believes They Have Real Opportunity Amid Challenges Faced by Traditional Lenders”

Flora Growth signed a definitive agreement with FGH to acquire 100% of all issued and outstanding shares by way of a statutory plan of agreement The deal is expected to close in December following the presentation of the agreement to shareholders; the acquisition will open Flora to the German and EU medical markets, increasing the … Continue reading “Flora Growth Corp. (NASDAQ: FLGC) Defines Path to Profitability and Portfolio Expansion with Proposed Franchise Global Health Inc. Acquisition”

The California Department of Cannabis Control (“DCC”) has reserved $20 million in funding for research prioritizing cannabis projects, including potency, health impact, medicinal use, legacy cannabis genetics, and industry health The medicinal and recreational cannabis market size in the US is anticipated to reach $33 billion in 2022, with a revenue outlook of $52.6 billion … Continue reading “REZYFi, Inc. Leverages Cannabis Industry Interests to Diversify Banking and Real Estate as DCC Prioritizes Research Project Funding”

Lexaria just completed its HYPER-H21-4 human clinical hypertension study, posting a sustained drop in blood pressure in normally active hypertensive patients With the success of this study, the company is working towards an IND application to seek FDA approval for its patented DehydraTECH(TM)-enabled CBD capsule formulation.  47% of adults live with hypertension but only 24% … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX) Aiming to Address Unmet Patient Needs of Hypertensive Patients”

Flora Growth is a cannabis cultivator and international brand developer with a strong base of operations at its licensed facility in northern Colombia Flora recently announced its plans to acquire multi-national operator Franchise Global Health (“FGH”), the latest of its strategic acquisitions designed to boost revenues and expand Flora’s international footprint FGH is focused on … Continue reading “Flora Growth Corp. (NASDAQ: FLGC) Agreement to Acquire Multi-national Cannabis Operator Positions Company for New Strategic Growth in Europe”

The CDC reported more than 670,000 annual deaths in the United States with high blood pressure as a primary or contributing cause Lexaria’s patented DehydraTECH(TM) technology has been shown, through HYPER-H21-4 study, to decrease high blood pressure in subjects through DehydraTECH-CBD-enabled dosing The global antihypertension drug market was valued at over $22.5 billion in revenue … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Zero Adverse Effects from Successful HYPER-H21-4 Study of DehydraTECH(TM)-CBD for High Blood Pressure”

After various successful shows across North and South America, Alternative Products Expo is coming to Tampa, Florida, this November 10-10, at Tampa’s Convention Center. The event has something for everyone. It features over 250 industry vendors, 20+ speakers from across the industry, and many contests and giveaways. Starting some years ago with a series of … Continue reading “Tampa Alternative Products Expo Brings Together The Local Community For Three Days of Festivity And Business Networking”

President Biden issued a pardon for federally incarcerated inmates with minor marijuana possession charges, urging governors to do the same at the state level The President also requested a reclassification of cannabis, as it is currently listed above other drugs which are key factors in the overdose epidemic Flora Growth, through its Colombian cultivation, is … Continue reading “Cannabis Regulation in the Spotlight During Midterm Elections at the Heels of Presidential Pardon; Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombian Stance to Manufacture Products at Lower Costs”

As marijuana legalization spreads across the United States, many companies have worked to address the industry-specific challenges that operators faced, particularly with regard to access to financial services, insurance, legal, compliance and regulatory issues as well as the security challenges created by the cash-only operations of many marijuana companies. There is speculation and hope that … Continue reading “420 with CNW — How Would the Passage of SAFE Banking Impact Marijuana-Specific Finance Companies?”

During the recently concluded midterm elections, marijuana measures were on the ballot in nearly two dozen California localities seeking to permit recreational sales to commence in those jurisdictions. A dozen of those measures got voter approval, and an analysis of each locality reveals interesting factors that seemed to have played a role in determining the … Continue reading “420 with CNW — Voters in California Approve 12 Measures Expanding Marijuana Retail”

Drug, racial and social-justice activists will be happy to know that House lawmakers will be discussing marijuana reform once the midterm elections draw to a close. Although the Biden administration was quick to act on its green-energy and electrification promises, there were plenty of valid complaints regarding the administration’s lack of action regarding cannabis reform. … Continue reading “420 with CNW — Congressional Subcommittee to Hold Marijuana Hearing Soon After Midterms”

It has been 10 years since Amendment 64, which legalized adult-use marijuana in Colorado, was passed and implemented. The proposed constitutional amendment had a number of arguments in support of legalizing marijuana, and we shine the spotlight on some of those arguments to see to what extent they have been vindicated. One major argument was … Continue reading “420 with CNW — Colorado’s Amendment 64 a Decade Later”

Governor Tony Evers (D), who has just been reelected as the governor of Wisconsin, has promised to include marijuana policy reform in his budget proposals due early in 2023. This pledge comes after Wisconsin voters in a number of counties and cities approved nonbinding questions in the midterm polls supporting the establishment of a legal … Continue reading “420 with CNW — Reelected Wisconsin Governor Promises to Include Marijuana Legalization in Budget Proposals”

President Joseph Biden made plenty of promises while on the campaign trail, including his pledge to offer marijuana pardons. One of his more progressive statements, the promise was met with praise from drug reform activists across the country. Last month, President Biden announced that he was taking steps to pardon everyone who had been federally … Continue reading “420 with CNW — 130-Plus NGOs Demand That Immigrants Be Included in Biden’s Cannabis Pardons”

There are an estimated 3.6 million registered medical cannabis patients in the United States with slightly more than 700,000 residing in the state of Florida. But, despite the fact that dozens of states have legalized medical marijuana and launched legal markets, the drug is still illegal at the federal level. This often leads to situations … Continue reading “420 with CNW — Federal Judge Dismisses Suit Challenging Ban on Gun Rights for Medical Cannabis Patients”

Marijuana industry watchers as well as retail buyers indicate that cannabis concentrates are registering more sales across the industry, particularly in mature markets. Frequent marijuana users are also taking a greater liking to concentrates. Brightfield Group, a Chicago-based cannabis analytics firm, says approximately 29% of all marijuana consumers admit that they have used cannabis concentrates … Continue reading “420 with CNW — Marijuana Consumers Opt for Concentrates as Product Prices Drop”

Related Editorial While the huge increase in U.S. consumer demand from hemp extracts and hemp product is largely credited as the reason for the boom in the number of hemp acres under cultivation, there is a significant additional part of the hemp-growth story to tell. With a pending acquisition in the cultivation supply market, Sugarmade … Continue reading “CannabisNewsAudio – Sugarmade, Inc. (SGMD) Poised to Profit as Hemp Demand Surges”

Related Editorial The surging hemp industry means exciting benefits for Kentucky. Hemp is big business in Kentucky. Among the companies working in the state is Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile), a supplier of hydroponic equipment that is now moving into hemp through an investment in Hempistry. In New York, a leading politician has been … Continue reading “CannabisNewsAudio – Sugarmade, Inc. (SGMD) Investing in Kentucky’s Hemp Sector”

Related Editorial In between growers and sellers lie several potential places for companies with expertise to firmly establish themselves in the burgeoning cannabis space. Savvy companies such as Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) recognize the potential payoff of being involved in the back end of the cannabis industry. The company’s wholly owned subsidiary … Continue reading “CannabisNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Expands Reach in Cannabis Industry to Include Processing, Manufacturing”

Related Editorial As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state’s thriving industry. Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile) is supporting many of these companies that have cultivation licenses by providing cultivation and extraction equipment. Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), one of … Continue reading “CannabisNewsAudio – Sugarmade, Inc. (SGMD) Providing Cultivation, Extraction Equipment as California Hemp Market Surges”

Related Editorial Mainstream retailers across the United States are embracing the growing popularity of the nonpsychoactive cannabinoid, cannabidiol (CBD), making room for CBD products on their prominent shelves. With the rise of these cannabis beauty products, major stores from luxury retailers Barney’s and Neiman Marcus down to Walgreens, Rite Aid and now Kroger are stocking … Continue reading “CannabisNewsAudio – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Secures Series of Noteworthy Deals with Top Retailers”

Related Editorial With demand outstripping supply, successful cannabis companies are following smart core strategies and reporting strong revenues. Golden Developing Solutions Inc. (OTC: DVLP) (DVLP Profile) has used a mix of acquisitions, diverse brands and products, and increased production footprint to meet customer demand and report significant revenue increases, including its strongest second-quarter numbers ever. … Continue reading “CannabisNewsAudio – Golden Developing Solutions Inc. (DVLP) Experiencing Strong Growth as Demand Rises in Booming Cannabis Sector”

Related Editorial Rising hemp production is putting pressure on processing. Sugarmade Inc. (OTCQB: SGMD) (SGMD Profile), a provider of cultivation equipment, is adding processors to its catalog of products, focusing on next-generation machinery. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) will be among the companies with a rising demand for processing, as it increases both … Continue reading “CannabisNewsAudio – Sugarmade, Inc. (SGMD) Exploring the New Generation of Hemp Processing Technology”

Related Editorial The cannabis sector continues its steady shift toward big business, big money and a focus on the value add of immaterial assets. TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) (TCAN Profile) has made several key acquisitions, creating a large operation with various licenses and recognized brands. HEXO Corp. (TSX: HEXO) (NYSE American: HEXO) … Continue reading “CannabisNewsAudio – TransCanna Holdings Inc. (CSE: TCAN) Flourishing in the Evolving Cannabis Sector through Key Acquisitions”